Skip to main content

Published locations for FDA expands inclisiran statin-adjunct indication to include primary prevention

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands inclisiran statin-adjunct indication to include primary prevention

User login

  • Reset your password
  • /content/fda-expands-inclisiran-statin-adjunct-indication-include-primary-prevention
  • /clinicianreviews/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication
  • /familypracticenews/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication
  • /internalmedicinenews/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication
  • /clinicalendocrinologynews/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct
  • /ecardiologynews/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication
  • /cardiology/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication-include
  • /endocrinology/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication
  • /internalmedicine/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication
  • /familymedicine/article/264056/lipid-disorders/fda-expands-inclisiran-statin-adjunct-indication